CVE-2024-34463
Published: 03 September 2024
Summary
CVE-2024-34463 is a medium-severity Improper Authorization (CWE-285) vulnerability in Bplmedicaltechnologies (inferred from references). Its CVSS base score is 5.1 (Medium).
Operationally, ranked in the top 13.0% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-34816
Vulnerability details
BPL Personal Weighing Scale PWS-01BT IND/09/18/599 devices send sensitive information in unencrypted BLE packets. (The packet data also lacks authentication and integrity protection.)
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Documented procedures facilitate correct implementation and ongoing management of authorization decisions.
Periodic reviews identify and correct flaws in authorization decisions or enforcement.
The control's documentation requirement reduces improper authorization by ensuring only mission-justified actions bypass authentication.
Establishing permitted attributes and values, plus auditing changes, ensures authorization decisions are based on correctly managed policy data.
Explicitly mandates authorizing remote access types before permitting connections, directly mitigating improper authorization.
The control explicitly requires authorization of each wireless access type prior to permitting connections.
Mandating explicit authorization of mobile device connections reduces the risk of improper authorization decisions for system access.
Specifying access authorizations for each account and requiring approvals for account requests enforces proper authorization decisions.